Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients. [PDF]
PLoS ONE, 2018 The relative efficacy of antiarrhythmic drugs (AADs) after electrical cardioversion are not well established. This study aimed to investigate the efficacies of different AADs for maintaining sinus rhythm (SR) after electrical cardioversion for atrial ...
Hye Bin Gwag +6 more
doaj +1 more source
Direct oral anticoagulants for electrical cardioversion
Кардиоваскулярная терапия и профилактика, 2021 The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using
A. N. Volovchenko +2 more
doaj +1 more source
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial. [PDF]
, 2020 Introduction This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects of ...
Camm, AJ +9 more
core +1 more source
Short and Intermediate Term Outcomes of the Convergent Procedure: Initial Experience in a Tertiary Referral Center [PDF]
, 2020 PURPOSE: The Convergent procedure is a hybrid, multidisciplinary treatment for symptomatic atrial fibrillation (AF) consisting of minimally invasive surgical epicardial ablation and percutaneous/catheter endocardial ablation.
Hirsh, Jeffrey +4 more
core +1 more source
Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]
, 2017 Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core +1 more source
Atrial Fibrillation in Eight New World Camelids. [PDF]
, 2015 BackgroundThere is limited information on the incidence of clinical signs, concurrent illness and treatment options for atrial fibrillation (AF) in New World Camelids (NWC).ObjectiveDescribe clinical signs and outcome of AF in NWC.AnimalsEight New World ...
Bozorgmanesh, R +5 more
core +1 more source
RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers [PDF]
, 2012 BACKGROUND Atrial fibrillation is a serious public health problem posing a considerable burden to not only patients, but the healthcare environment due to high rates of morbidity, mortality, and medical resource utilization. There are limited data on the
AJ Camm +36 more
core +3 more sources
Рациональная фармакотерапия в кардиологии, 2016 Atrial fibrillation (AF) is the most common cardiac cause of systemic embolism and cardioembolic stroke. The risk of thromboembolic complications increases significantly when performing for electrical cardioversion.
N. A. Novikova, A. N. Volovchenko
doaj +1 more source
The Function of Cochlear Implant After Cardioversion in a Patient With Atrial Flutter: A Case Report
Ear, Nose & Throat Journal, 2023 Hearing loss in older people can cause communication impairments, decreased quality of life, social isolation, depression, and dementia. Cochlear implant surgery is an effective treatment for older patients with hearing loss who cannot achieve ...
Hong Chan Kim MD +3 more
doaj +1 more source
Initial Energy for External Electrical Cardioversion of Atrial Fibrillation
Arquivos Brasileiros de Cardiologia, 2002 OBJECTIVE - To investigate the initial energy level required for electrical cardioversion of atrial fibrillation (AF). METHODS - We studied patients undergoing electrical cardioversion in the 1st Multicenter Trial of SOCESP.
Edilberto Figueiredo +2 more
doaj +1 more source